Keyword: research & development

Webinar Series: The Future of Scientific Product Innovation and Manufacturing in the Life Sciences Industry

18.05.2020 - Achieve business excellence with end-to-end scientific collaboration platform for faster drug-to-market & agile medical device manufacturing. Join us for our webinar series to...

Reserach & Innovation

Expert Webinar: Efficient and Innovative Labs in the 21st Century

01.04.2020 - We probably can all agree that labs in the 21st century are not working anymore like in the past. Workflows are becoming more digital and connected, environments are harmonized and...

Markets & Companies

Ireland’s Thriving Pharma and Chemicals Producers Optimistic about Brexit

24.11.2017 - Of the remaining post-Brexit 27 member states of the European Union, Ireland looks likely to suffer the most economically, and also possibly politically, as a result of the UK’s...

Plant Construction & Process Technology

New Rules For Pharma

27.09.2017 - Pharmaceutical companies are experiencing numerous challenges such as increasing cost pressures, declining autonomy or protocol-driven care. The reaction has to go beyond...

News

Cambrex Invests in Swedish cGMP Facility

09.06.2017 - US active pharmaceutical ingredients (API) manufacturer Cambrex Corporation has announced the expansion of large-scale manufacturing capacity at its cGMP plant in Karlskoga, Sweden...

Strategy & Management

Cerbios' new State-of the-art R&D Centre for HPAI and mAb Development

21.09.2016 - On February 15th, 2016, Cerbios Pharma officially opened its new R&D Centre in Lugano, Switzerland. During the past 15 years, Cerbios has heavily invested in infrastructures, in...

Markets & Companies

Supplier-Customer Relationship

05.04.2016 - Chemical companies both large and small are more comfortable today than ever before with outsourced contract manufacturing, or tolling, as it’s commonly called. For many tolling is...

Strategy & Management

The New Globalism

04.04.2016 - In September of 2015, Siegfried completed all closing conditions for its acquisition of the custom synthesis business of BASF and parts of the German group’s active pharmaceutical...